Evidence map›Paper›PMID 32059540›Full record

ArticleAnimals : an open access journal from MDPI2020

Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research-Alternatives Should Be Explored.

Yoram Gutfreund

Abstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yoram GutfreundDepartment of Neurobiology, Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3100000, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using animals in scientific research is commonly justified on the utilitarian basis that the benefits of scientific progress to human health and society exceed by far the harm inflicted on animals. In an attempt to ensure that this is indeed the case for every research project, legislation and guidelines increasingly demand the application of harm-benefit analysis (HBA) as part of the approval process of animal research protocols. The ethical principle of HBA asserts that the costs of an action should be weighed against the expected benefits. Any action that may inflict harm can only be approved if it is associated with a greater benefit. This principle is intuitively appealing but how to use it as a practical rule for ethical decisions is a difficult question. The main difficulty is that the future benefits of most scientific research are unmeasurable, unpredictable and are not manifested at the level of the individual project. Applying HBA in such cases may impede scientific progress by inducing a bias against basic research. Moreover, it can lead to the toleration of unnecessary harm to animals in research. Given these caveats of HBA, I call policy-makers to reconsider the place of HBA in animal research. Instead, I support an alternative guideline which is based on replacing the HBA principle (that the expected benefits of the research must exceed the harms caused to the animals) with two independent but mutually necessary principles: (1) any research using an animal must carry a benefit for society and (2) the harm inflicted to an animal in an experiment must be minimal and scientifically justified. I argue that rigorous harm-analysis, which is not weighted against obscure benefits, can increase the over-all benefits of research while reducing the harms to animals.

Indexed as

the 3Rs, cost-benefit, animal research, animal experiments, IACUC

Identifiers

PMID32059540
PMCPMC7070552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.